Alibaba
BABA
Micron Technology
MU
NVIDIA
NVDA
Cisco
CSCO
Netflix
NFLX
US Stock MarketDetailed Quotes
TRML Tourmaline Bio
- 13.830
- +0.740+5.65%
Close Feb 14 16:00 ET
- 14.570
- +0.740+5.35%
Post 20:01 ET
354.64MMarket Cap-6.68P/E (TTM)
13.965High13.150Low229.39KVolume13.150Open13.090Pre Close3.13MTurnover1.80%Turnover RatioLossP/E (Static)25.64MShares48.31052wk High1.10P/B176.09MFloat Cap12.12052wk Low--Dividend TTM12.73MShs Float88.039Historical High--Div YieldTTM6.23%Amplitude3.953Historical Low13.631Avg Price1Lot Size
Tourmaline Bio News
Tourmaline Bio | EFFECT: Others
Tourmaline Bio | 424B5: Prospectus
Tourmaline Bio | 424B5: Prospectus
Talaris Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Talaris Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Talaris Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Talaris Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Talaris Therapeutics | 424B3: Prospectus
Talaris Therapeutics | EFFECT: Others
Talaris Therapeutics | S-4/A: Registration of securities issued in business combination transactions (Amendment)
Talaris Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Talaris Therapeutics | S-4/A: Registration of securities issued in business combination transactions (Amendment)
Talaris Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Talaris Therapeutics | S-4/A: Registration of securities issued in business combination transactions (Amendment)
Talaris Therapeutics | S-4: Registration of securities issued in business combination transactions
Talaris Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Talaris Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Talaris Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Talaris Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Talaris Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.